KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Equity Average (2016 - 2026)

Medpace Holdings filings provide 11 years of Equity Average readings, the most recent being $528.7 million for Q1 2026.

  • On a quarterly basis, Equity Average fell 25.49% to $528.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $528.7 million, a 25.49% decrease, with the full-year FY2025 number at $642.3 million, down 7.21% from a year prior.
  • Equity Average hit $528.7 million in Q1 2026 for Medpace Holdings, up from $376.4 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $853.5 million in Q4 2024 to a low of $233.0 million in Q3 2025.
  • Median Equity Average over the past 5 years was $444.1 million (2022), compared with a mean of $519.4 million.
  • Biggest five-year swings in Equity Average: soared 94.38% in 2024 and later tumbled 71.67% in 2025.
  • Medpace Holdings' Equity Average stood at $368.1 million in 2022, then surged by 39.88% to $514.9 million in 2023, then soared by 65.75% to $853.5 million in 2024, then tumbled by 55.9% to $376.4 million in 2025, then soared by 40.48% to $528.7 million in 2026.
  • The last three reported values for Equity Average were $528.7 million (Q1 2026), $376.4 million (Q4 2025), and $233.0 million (Q3 2025) per Business Quant data.